247133-56-8

Basic information

• Product Name: N-[4-Cyano-2-[4-(1-tert-butoxycarbonylpiperidin-4-yloxy)phenoxyacetamido]-phenyl]glycine tert-Butyl Ester
• Synonyms: N-[4-Cyano-2-[4-(1-tert-butoxycarbonylpiperidin-4-yloxy)phenoxyacetamido]-phenyl]glycine tert-Butyl Ester
• CAS NO: 247133-56-8
• Molecular Weight: 580.681
• Mol File: 247133-56-8.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: N-[4-Cyano-2-[4-(1-tert-butoxycarbonylpiperidin-4-yloxy)phenoxyacetamido]-phenyl]glycine tert-Butyl Ester(CAS DataBase Reference)
• NIST Chemistry Reference: N-[4-Cyano-2-[4-(1-tert-butoxycarbonylpiperidin-4-yloxy)phenoxyacetamido]-phenyl]glycine tert-Butyl Ester(247133-56-8)
• EPA Substance Registry System: N-[4-Cyano-2-[4-(1-tert-butoxycarbonylpiperidin-4-yloxy)phenoxyacetamido]-phenyl]glycine tert-Butyl Ester(247133-56-8)

Safety Data

• Hazardous Substances Data: 247133-56-8(Hazardous Substances Data)

Upstream product

• 247132-60-1 4-[4-[N-Benzyloxycarbonyl-N-(2-tert-butoxycarbonylmethylamino-5-cyanophenyl)carbamoylmethylamino]phenoxy]piperidine-1-carboxylic Acid tert-Butyl Ester 
• 247133-54-6 ethyl 4-(1-tert-butoxycarbonylpiperidin4-yloxy)-phenoxyacetate 
• 247132-58-7 N-(4-Cyano-2-nitrophenyl)glycine tert-butyl ester 
• 109384-19-2 t-butyl 4-hydroxy piperidine-1-carboxylate 
• 142717-44-0 Ethyl 2-(4-benzyloxyphenoxy)ethanoate 
• 20872-28-0 ethyl 2-(4-hydroxyphenoxy)acetate 
• 6456-74-2 Glycine tert-butyl ester 
• 939-80-0 4-chloro-3-nitrobenzonitrile 
• 247132-59-8 N-(2-amino-4-cyanophenyl)glycine tert-butyl ester 
• 247133-55-7 4-(1-tert-butoxycarbonylpiperidin-4-yloxy)phenoxyacetic acid 

Downstream Products

• 247133-57-9 5-Cyano-2-[4-(1-tert-butoxycarbonylpiperidin-4-yloxy)phenoxymethyl]-benzimidazole-1-acetic Acid 

Relevant articles and documents

Structure-activity relationships of potent and selective factor Xa inhibitors: benzimidazole derivatives with the side chain oriented to the prime site of factor Xa.

A series of benzimidazole derivatives with the side chain on the nitrogen atom oriented to the prime site of factor Xa (FXa) were designed and synthesized. Compounds with substituted aminocarbonylmethyl groups as the side chain showed potent FXa inhibitor